Magdalena Tary-Lehmann, M.D., Ph.D., Associate Professor


Co-Founder & Chief Scientific Officer with 25 years of ELISPOT experience

Dr. Tary-Lehmann received her M.D. and Ph.D. in Immunology, both from the University of Tübingen, Germany. Her postdoctoral training in Immunology was at the University of California, Los Angeles. Thereafter, she went on to Case Western Reserve University as a faculty member, where she was awarded tenure and appointed Associate Professor in the Department of Pathology in 2003. As Chief Scientific Officer for CTL, she provides guidance and oversight for technical operations, ensuring the ongoing scientific excellence of the company. For more than 10 years, she has worked with various pharmaceutical and biotechnology clients in developing, validating and performing regulated immunology assays in CTL’s GLP- and CLIA- compliant laboratory. 

Dr. Tary-Lehmann has authored 75 peer-reviewed publications in the field of T cell immunology. Among the highlights have been:

View Dr. Tary-Lehmann's list of publications.